Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

THE SYSTEMIC METABOLIC PROFILE EARLY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: EFFECTS OF ADEQUATE ENERGY SUPPORT ADMINISTERED THROUGH ENTERAL FEEDING TUBE.

Tvedt THA, Skaarud KJ, Tjønnfjord GE, Gedde-Dahl T, Iversen PO, Bruserud Ø.

Biol Blood Marrow Transplant. 2019 Oct 14. pii: S1083-8791(19)30661-5. doi: 10.1016/j.bbmt.2019.10.005. [Epub ahead of print]

PMID:
31622769
2.

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL.

Skånland SS, Cremaschi A, Bendiksen H, Hermansen JU, Thimiri Govinda Raj DB, Munthe LA, Tjønnfjord GE, Taskén K.

Leukemia. 2019 Aug 30. doi: 10.1038/s41375-019-0569-7. [Epub ahead of print]

PMID:
31471562
3.

Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients.

Skaarud KJ, Veierød MB, Lergenmuller S, Bye A, Iversen PO, Tjønnfjord GE.

Bone Marrow Transplant. 2019 Aug 27. doi: 10.1038/s41409-019-0638-6. [Epub ahead of print]

PMID:
31455897
4.

Cold agglutinin disease: current challenges and future prospects.

Berentsen S, Röth A, Randen U, Jilma B, Tjønnfjord GE.

J Blood Med. 2019 Apr 9;10:93-103. doi: 10.2147/JBM.S177621. eCollection 2019.

5.

Surgical procedures in patients with severe haemophilia 1997–2014.

Andersen MF, Holme PA, Tjønnfjord GE.

Tidsskr Nor Laegeforen. 2019 May 6;139(8). doi: 10.4045/tidsskr.18.0592. Print 2019 May 7. Norwegian.

6.

Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality.

Torkildsen S, Gorunova L, Heim S, Tjønnfjord GE, Spetalen S, Risberg B, Tran HTT, Panagopoulos I.

Cancer Genomics Proteomics. 2019 May-Jun;16(3):175-178. doi: 10.21873/cgp.20123.

7.

Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway.

Lenartova A, Randen U, Johannesen TB, Tjønnfjord GE.

Cancer Epidemiol. 2019 Jun;60:128-133. doi: 10.1016/j.canep.2019.04.002. Epub 2019 Apr 12.

PMID:
30986631
8.

Inheritance of Susceptibility to Malignant Blood Disorders.

Jønsson V, Awan H, Jones ND, Johannesen TB, Steig BÁ, Andosdottir G, Tjønnfjord GE.

Sci Rep. 2019 Feb 21;9(1):2444. doi: 10.1038/s41598-019-38879-y.

9.

The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function.

Chellappa S, Kushekhar K, Munthe LA, Tjønnfjord GE, Aandahl EM, Okkenhaug K, Taskén K.

J Immunol. 2019 Mar 1;202(5):1397-1405. doi: 10.4049/jimmunol.1701703. Epub 2019 Jan 28.

PMID:
30692213
10.

Cryopreservation of primary B cells minimally influences their signaling responses.

Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS.

Sci Rep. 2018 Dec 5;8(1):17651. doi: 10.1038/s41598-018-36121-9.

11.

A Case of Posttransfusion Purpura with Severe Refractory Thrombocytopenia but No Cutaneous Manifestations.

Bhamra JS, Iversen PO, Titze TK, Tjønnfjord GE, Akkök ÇA.

Case Rep Hematol. 2018 Oct 29;2018:8187659. doi: 10.1155/2018/8187659. eCollection 2018.

12.

Continuous infusion of simoctocog alfa in haemophilia A patients undergoing surgeries.

Holme PA, Tjønnfjord GE.

Haemophilia. 2019 Jan;25(1):54-59. doi: 10.1111/hae.13625. Epub 2018 Nov 5.

PMID:
30394617
13.

Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial.

Skaarud KJ, Hjermstad MJ, Bye A, Veierød MB, Gudmundstuen AM, Lundin KEA, Distante S, Brinch L, Tjønnfjord GE, Iversen PO.

Clin Nutr ESPEN. 2018 Dec;28:59-66. doi: 10.1016/j.clnesp.2018.08.002. Epub 2018 Aug 29.

PMID:
30390894
14.

STIM1 R304W causes muscle degeneration and impaired platelet activation in mice.

Gamage TH, Gunnes G, Lee RH, Louch WE, Holmgren A, Bruton JD, Lengle E, Kolstad TRS, Revold T, Amundsen SS, Dalen KT, Holme PA, Tjønnfjord GE, Christensen G, Westerblad H, Klungland A, Bergmeier W, Misceo D, Frengen E.

Cell Calcium. 2018 Dec;76:87-100. doi: 10.1016/j.ceca.2018.10.001. Epub 2018 Oct 5.

PMID:
30390422
15.

Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis.

Tangen JM, Tjønnfjord GE, Gulbrandsen N, Gedde-Dahl T, Stormorken E, Anderson K, Vo CD, Schjesvold FH; For Oslo Myeloma Center.

BMC Cancer. 2018 Aug 8;18(1):801. doi: 10.1186/s12885-018-4722-x.

16.

Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.

Habberstad AH, Tran HTT, Randen U, Spetalen S, Dybedal I, Tjønnfjord GE, Dahm AEA.

J Med Case Rep. 2018 Apr 24;12(1):105. doi: 10.1186/s13256-018-1663-6.

17.

Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia.

Rogne M, Svaerd O, Madsen-Østerbye J, Hashim A, Tjønnfjord GE, Staerk J.

J Cell Mol Med. 2018 May;22(5):2846-2855. doi: 10.1111/jcmm.13579. Epub 2018 Mar 7.

18.

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

Myhrvold IK, Cremaschi A, Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS.

Oncotarget. 2018 Jan 4;9(10):9273-9284. doi: 10.18632/oncotarget.23949. eCollection 2018 Feb 6.

19.

Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway.

Diep PP, Melberg HO, Brinch L, Buechner J, Fløisand Y, Gedde-Dahl T, Loge JH, Tjønnfjord GE, Ruud E.

Bone Marrow Transplant. 2018 May;53(5):657-660. doi: 10.1038/s41409-018-0091-y. Epub 2018 Jan 22. No abstract available.

PMID:
29358600
20.

Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease.

Małecka A, Trøen G, Tierens A, Østlie I, Małecki J, Randen U, Wang J, Berentsen S, Tjønnfjord GE, Delabie JMA.

Br J Haematol. 2018 Dec;183(5):838-842. doi: 10.1111/bjh.15063. Epub 2017 Dec 19. No abstract available.

PMID:
29265349
21.

DEK-NUP214-Fusion Identified by RNA-Sequencing of an Acute Myeloid Leukemia with t(9;12)(q34;q15).

Panagopoulos I, Gorunova L, Torkildsen S, Tjønnfjord GE, Micci F, Heim S.

Cancer Genomics Proteomics. 2017 Nov-Dec;14(6):437-443. Review.

22.

Continuous infusion of coagulation factor concentrates during intensive treatment.

Holme PA, Tjønnfjord GE, Batorova A.

Haemophilia. 2018 Jan;24(1):24-32. doi: 10.1111/hae.13331. Epub 2017 Sep 5. Review.

PMID:
28873263
23.

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.

Berentsen S, Randen U, Oksman M, Birgens H, Tvedt THA, Dalgaard J, Galteland E, Haukås E, Brudevold R, Sørbø JH, Næss IA, Malecka A, Tjønnfjord GE.

Blood. 2017 Jul 27;130(4):537-541. doi: 10.1182/blood-2017-04-778175. Epub 2017 May 22.

PMID:
28533306
24.

Prophylactic use of eculizumab during surgery in chronic cold agglutinin disease.

Tjønnfjord E, Vengen ØA, Berentsen S, Tjønnfjord GE.

BMJ Case Rep. 2017 May 9;2017. pii: bcr-2016-219066. doi: 10.1136/bcr-2016-219066.

25.

Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia.

Vojdeman FJ, Herman SEM, Kirkby N, Wiestner A, van T' Veer MB, Tjønnfjord GE, Itälä-Remes MA, Kimby E, Farooqui MZ, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MCJ, van Oers MHJ, Geisler CH, Niemann CU.

Leuk Lymphoma. 2017 Oct;58(10):2356-2362. doi: 10.1080/10428194.2017.1285027. Epub 2017 Feb 7.

26.

Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice.

Wang D, Fløisand Y, Myklebust CV, Bürgler S, Parente-Ribes A, Hofgaard PO, Bogen B, Taskén K, Tjønnfjord GE, Schjesvold F, Dalgaard J, Tveita A, Munthe LA.

Leukemia. 2017 Oct;31(10):2114-2121. doi: 10.1038/leu.2017.69. Epub 2017 Feb 24.

PMID:
28232741
27.

National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data.

Lenartova A, Johannesen TB, Tjønnfjord GE.

Cancer Med. 2016 Dec;5(12):3588-3595. doi: 10.1002/cam4.849. Epub 2016 Nov 4.

28.

Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.

Fløisand Y, Lundin KEA, Lazarevic V, Kristiansen JD, Osnes LTN, Tjønnfjord GE, Reims HM, Gedde-Dahl T.

Biol Blood Marrow Transplant. 2017 Jan;23(1):172-175. doi: 10.1016/j.bbmt.2016.10.009. Epub 2016 Oct 21.

29.

Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR, Wiszniewski W, Fevang B, Aukrust P, Tjønnfjord GE, Gedde-Dahl T, Hjorth-Hansen H, Dybedal I, Nordøy I, Jørgensen SF, Abrahamsen TG, Øverland T, Bechensteen AG, Skogen V, Osnes LTN, Kulseth MA, Prescott TE, Rustad CF, Heimdal KR, Belmont JW, Rider NL, Chinen J, Cao TN, Smith EA, Caldirola MS, Bezrodnik L, Lugo Reyes SO, Espinosa Rosales FJ, Guerrero-Cursaru ND, Pedroza LA, Poli CM, Franco JL, Trujillo Vargas CM, Aldave Becerra JC, Wright N, Issekutz TB, Issekutz AC, Abbott J, Caldwell JW, Bayer DK, Chan AY, Aiuti A, Cancrini C, Holmberg E, West C, Burstedt M, Karaca E, Yesil G, Artac H, Bayram Y, Atik MM, Eldomery MK, Ehlayel MS, Jolles S, Flatø B, Bertuch AA, Hanson IC, Zhang VW, Wong LJ, Hu J, Walkiewicz M, Yang Y, Eng CM, Boerwinkle E, Gibbs RA, Shearer WT, Lyle R, Orange JS, Lupski JR.

J Allergy Clin Immunol. 2017 Jan;139(1):232-245. doi: 10.1016/j.jaci.2016.05.042. Epub 2016 Jul 16. Erratum in: J Allergy Clin Immunol. 2018 Feb;141(2):832.

30.

The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia.

Vojdeman FJ, Van't Veer MB, Tjønnfjord GE, Itälä-Remes M, Kimby E, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MC, van Oers MH, Geisler CH.

Leuk Lymphoma. 2017 Mar;58(3):594-600. doi: 10.1080/10428194.2016.1213831. Epub 2016 Aug 2. Erratum in: Leuk Lymphoma. 2017 Mar;58(3):758.

PMID:
27484290
31.

Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity.

Małecka A, Trøen G, Tierens A, Østlie I, Małecki J, Randen U, Berentsen S, Tjønnfjord GE, Delabie JM.

Haematologica. 2016 Sep;101(9):e361-4. doi: 10.3324/haematol.2016.146126. Epub 2016 May 19. No abstract available.

32.

Persistent bone marrow depression following short-term treatment with temozolomide.

Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P.

BMJ Case Rep. 2016 Apr 29;2016. pii: bcr2016215797. doi: 10.1136/bcr-2016-215797.

33.

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome.

Barratt-Due A, Fløisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE.

Rheumatology (Oxford). 2016 Jul;55(7):1337-9. doi: 10.1093/rheumatology/kew040. Epub 2016 Apr 22. No abstract available.

34.

Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells.

Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA.

Haematologica. 2016 Feb;101(2):e59-62. doi: 10.3324/haematol.2015.135590. Epub 2015 Nov 20. No abstract available.

35.

High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence.

von Krogh AS, Quist-Paulsen P, Waage A, Langseth ØO, Thorstensen K, Brudevold R, Tjønnfjord GE, Largiadèr CR, Lämmle B, Kremer Hovinga JA.

J Thromb Haemost. 2016 Jan;14(1):73-82. doi: 10.1111/jth.13186. Epub 2016 Jan 8.

36.

Therapeutic complement inhibition – from experimental to clinical medicine.

Lappegård KT, Bjerre A, Tjønnfjord GE, Mollnes TE.

Tidsskr Nor Laegeforen. 2015 Oct 20;135(19):1745-9. doi: 10.4045/tidsskr.15.0049. eCollection 2015 Oct 20. Review. English, Norwegian.

37.

[Familial occurrence of chronic lymphatic leukemia in Norway].

Tjønnfjord GE, Jønsson V, Ly BE, Johannesen TB.

Tidsskr Nor Laegeforen. 2015 Oct 6;135(18):1626. doi: 10.4045/tidsskr.15.0947. eCollection 2015 Oct 6. Norwegian. No abstract available.

38.

[Chronic lymphatic leukemia in Norway-incidence and prognosis at diagnosis time].

Tjønnfjord GE, Ly BE, Johannesen TB, Tierens A, Beiske K, Heim S, Jønsson V.

Tidsskr Nor Laegeforen. 2015 Oct 6;135(18):1626. doi: 10.4045/tidsskr.15.0946. eCollection 2015 Oct 6. Norwegian. No abstract available.

39.

Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32).

Torkildsen S, Gorunova L, Beiske K, Tjønnfjord GE, Heim S, Panagopoulos I.

PLoS One. 2015 Jul 17;10(7):e0132736. doi: 10.1371/journal.pone.0132736. eCollection 2015.

40.

Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000-2010.

Nissen-Meyer LS, Tjønnfjord GE, Golebiowska E, Kjeldsen-Kragh J, Akkök ÇA.

Tidsskr Nor Laegeforen. 2015 Jun 16;135(11):1039-43. doi: 10.4045/tidsskr.14.0444. eCollection 2015 Jun 16. English, Norwegian.

41.

Cold agglutinin-mediated autoimmune hemolytic anemia.

Berentsen S, Randen U, Tjønnfjord GE.

Hematol Oncol Clin North Am. 2015 Jun;29(3):455-71. doi: 10.1016/j.hoc.2015.01.002. Epub 2015 Mar 12. Review.

PMID:
26043385
42.

Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study.

Tangen JM, Tierens A, Caers J, Binsfeld M, Olstad OK, Trøseid AM, Wang J, Tjønnfjord GE, Hetland G.

Biomed Res Int. 2015;2015:718539. doi: 10.1155/2015/718539. Epub 2015 Jan 18.

43.

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.

Ghanima W, Khelif A, Waage A, Michel M, Tjønnfjord GE, Romdhan NB, Kahrs J, Darne B, Holme PA; RITP study group.

Lancet. 2015 Apr 25;385(9978):1653-61. doi: 10.1016/S0140-6736(14)61495-1. Epub 2015 Feb 5.

PMID:
25662413
44.

Monitoring bypassing agent therapy - a prospective crossover study comparing thromboelastometry and thrombin generation assay.

Tran HT, Sørensen B, Bjørnsen S, Pripp AH, Tjønnfjord GE, Andre Holme P.

Haemophilia. 2015 Mar;21(2):275-83. doi: 10.1111/hae.12570. Epub 2014 Dec 18.

PMID:
25521720
45.

Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism.

Bürgler S, Gimeno A, Parente-Ribes A, Wang D, Os A, Devereux S, Jebsen P, Bogen B, Tjønnfjord GE, Munthe LA.

J Immunol. 2015 Jan 15;194(2):827-35. doi: 10.4049/jimmunol.1401350. Epub 2014 Dec 10.

46.

[Allogeneic stem-cell transplantation in adults 1985-2012: results and development].

Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T Jr, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y.

Tidsskr Nor Laegeforen. 2014 Sep 2;134(16):1569-75. doi: 10.4045/tidsskr.13.1415. eCollection 2014 Sep 2. Norwegian.

47.

Identification of copy number variants from exome sequence data.

Samarakoon PS, Sorte HS, Kristiansen BE, Skodje T, Sheng Y, Tjønnfjord GE, Stadheim B, Stray-Pedersen A, Rødningen OK, Lyle R.

BMC Genomics. 2014 Aug 7;15:661. doi: 10.1186/1471-2164-15-661.

48.

Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice.

Ruffini PA, Os A, Dolcetti R, Tjønnfjord GE, Munthe LA, Bogen B.

J Transl Med. 2014 Jul 25;12:207. doi: 10.1186/1479-5876-12-207.

49.

Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies.

Bruserud Ø, Tvedt TH, Paulsen PQ, Ahmed AB, Gedde-Dahl T, Tjønnfjord GE, Slåstad H, Heldal D, Reikvam H.

Cancer Immunol Immunother. 2014 Aug;63(8):757-77. doi: 10.1007/s00262-014-1578-z. Epub 2014 Jul 5. Review.

PMID:
24997173
50.

Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry.

Zeidler C, Grote UA, Nickel A, Brand B, Carlsson G, Cortesão E, Dufour C, Duhem C, Notheis G, Papadaki HA, Tamary H, Tjønnfjord GE, Tucci F, Van Droogenbroeck J, Vermylen C, Voglova J, Xicoy B, Welte K.

Haematologica. 2014 Aug;99(8):1395-402. doi: 10.3324/haematol.2013.099101. Epub 2014 Jul 4.

Supplemental Content

Loading ...
Support Center